Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Fosun International Limited    0656   HK0656038673

FOSUN INTERNATIONAL LIMITED (0656)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Fosun International : ANNOUNCEMENT - CHANGE OF DIRECTORS OF FOSUN HIGH TECHNOLOGY

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 04:39pm CEST

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

ANNOUNCEMENT CHANGE OF DIRECTORS OF FOSUN HIGH TECHNOLOGY

Shanghai Fosun High Technology (Group) Co., Ltd. ("Fosun High Technology") is a wholly-owned subsidiary of Fosun International Limited (the "Company"). The recent change of directors of Fosun High Technology, namely the resignation of Mr. Guo Guangchang, the chairman of the Company and Mr. Wang Qunbin, the chief executive officer of the Company, as directors of Fosun High Technology, is at the subsidiary level of the Company only and does not involve any change of the directors of the Company.

The change of the directors of Fosun High Technology is a normal personnel change of the subsidiary of the Company. There is no change of the ultimate controlling person of the Company and its subsidiaries (the "Group"). The Group's daily management, operation and production remain normal.

Subsequent to the above mentioned change, Mr. Guo and Mr. Wang will be able to focus more on their role as directors of the Company. Both of them will continue leading the strategic planning, major projects and business opportunities promotion of the Group. Meanwhile, as the global partner model of the Group matures, the above mentioned change will also provide the next generation of management team with more and greater responsibilities.

By Order of the Board

Fosun International Limited

Guo Guangchang

Chairman

10 November 2017

As at the date of this announcement, the executive directors of the Company are Mr. Guo Guangchang, Mr. Wang Qunbin, Mr. Chen Qiyu, Mr. Xu Xiaoliang, Mr. Qin Xuetang, Mr. Wang Can, Ms. Kang Lan and Mr. Gong Ping; and the independent non-executive directors are Mr. Zhang Shengman, Mr. Zhang Huaqiao, Mr. David T. Zhang, Mr. Yang Chao and Dr. Lee Kai-Fu.

Fosun International Limited published this content on 10 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 November 2017 15:38:12 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FOSUN INTERNATIONAL LIMITE
02:58pFosun looks to promote province worldwide
AQ
02:34pFosun looks to promote province worldwide
AQ
07/12FOSUN INTERNATIONAL : Progress update on discloseable transactions in relation t..
PU
07/07France's CDC to decide on buying out Veolia in JV at end summer
RE
07/05SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma controlling holder adds 500,000 H s..
AQ
07/05FOSUN INTERNATIONAL : Intl to spin off integrated tourism business
AQ
07/04FOSUN INTERNATIONAL : Voluntary announcement in relation to proposed spin-off an..
PU
07/04SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma controlling holder adds 2.01m H sha..
AQ
07/03EVES : Phase two for Wolves plans
AQ
06/28Exclusive - Generali to start exclusive talks to sell German life book to Vir..
RE
More news
News from SeekingAlpha
04/08WEEK IN REVIEW : Concord Medical Raises $240 Million For China Radiology Service.. 
03/28Fosun International, Ltd. 2017 Q4 - Results - Earnings Call Slides 
03/25WEEK IN REVIEW : James Watson To Lead New Shenzhen Biopharma Research Center 
03/04WEEK IN REVIEW : Grail Plans $500 Million Hong Kong IPO For Cancer Diagnostics 
02/25WEEK IN REVIEW : Taiwan Liposome Files For $50 Million Secondary IPO In The U.S. 
Financials ( CNY)
Sales 2018 95 235 M
EBIT 2018 4 207 M
Net income 2018 14 268 M
Debt 2018 77 368 M
Yield 2018 2,61%
P/E ratio 2018 6,95
P/E ratio 2019 6,24
EV / Sales 2018 1,92x
EV / Sales 2019 1,76x
Capitalization 105 B
Chart FOSUN INTERNATIONAL LIMITE
Duration : Period :
Fosun International Limite Technical Analysis Chart | 0656 | HK0656038673 | 4-Traders
Technical analysis trends FOSUN INTERNATIONAL LIMITE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 20,2  CNY
Spread / Average Target 65%
EPS Revisions
Managers
NameTitle
Qun Bin Wang Chief Executive Officer & Executive Director
Qi Yu Chen Co-President & Executive Director
Xiao Liang Xu Co-President & Executive Director
Guang Chang Guo Chairman
Can Wang Chief Financial Officer, Executive Director & SVP
Sector and Competitors
1st jan.Capitalization (M$)
FOSUN INTERNATIONAL LIMITED-17.15%15 690
ARCELORMITTAL-6.12%30 359
POSCO--.--%24 449
NUCOR0.85%20 396
NIPPON STEEL & SUMITOMO METAL CORP-28.04%17 923
NOVOLIPETSK STEEL PAO--.--%15 216